Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine

Pilot studies of pharmacokinetics and pharmacodynamics of new photosensitizer liposomal boronated chlorine in mice with melanoma В16 were performed. Dynamics of drug accumulation in tumor and normal tissue (level of accumulation in tissues was assessed by means of fl uorescence) was studied. For int...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. S. Osipchuk, M. A. Kaplan, V. V. Drozhzhina
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2015-06-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/55
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409401276858368
author Yu. S. Osipchuk
M. A. Kaplan
V. V. Drozhzhina
author_facet Yu. S. Osipchuk
M. A. Kaplan
V. V. Drozhzhina
author_sort Yu. S. Osipchuk
collection DOAJ
description Pilot studies of pharmacokinetics and pharmacodynamics of new photosensitizer liposomal boronated chlorine in mice with melanoma В16 were performed. Dynamics of drug accumulation in tumor and normal tissue (level of accumulation in tissues was assessed by means of fl uorescence) was studied. For intraperitoneal injection at a dose of 5 mg/kg the drug was shown to accumulate gradually in tumor and normal tissues with maximal fl uorescence values in 2–3 h after injection. Then fl uorescence intensity in tissues gradually decreased, achieving nearly initial base-line in 120 h after beginning of the study. The hotosensitizer accumulated in tumor tissue with average selectivity: contrast index for maximal drug accumulation in tissues accounted for 1.7–2.8. According to obtained data for following research the time interval between drug injection and irradiation of 3h was chosen. On the second stage of the study dependence of photodynamic therapy effi cacy on different parameters including photosensitizer dose for intraperitoneal injection (5–10 mg/kg), light dose (150–300 J/cm2) and power density (0.25–0.51 mW/cm2). The irradiation was performed by semiconductor laser on wavelength of 662±1 nm. The effi cacy was maximal for following regimen: photosensitizer dose of 5 mg/kg, light dose of 300 J/cm2, power intensity of 0.44 mW/cm2. For this regimen at the end of follow-up (21 days) complete tumor regression was obtained in 75% of animals and average coeffi cient of absolute tumor growth accounted for only 7.82.
format Article
id doaj-art-ec0a18623de349a9bf3d2446341ecb0f
institution Kabale University
issn 2413-9432
language Russian
publishDate 2015-06-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-ec0a18623de349a9bf3d2446341ecb0f2025-08-20T03:35:29ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322015-06-01423810.24931/2413-9432-2015-4-2-3-853Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorineYu. S. Osipchuk0M. A. Kaplan1V. V. Drozhzhina2A.F.Tsyb MRRC – branch of FSI « NMRRC» of Russian Ministry of Health, ObninskA.F.Tsyb MRRC – branch of FSI « NMRRC» of Russian Ministry of Health, ObninskA.F.Tsyb MRRC – branch of FSI « NMRRC» of Russian Ministry of Health, ObninskPilot studies of pharmacokinetics and pharmacodynamics of new photosensitizer liposomal boronated chlorine in mice with melanoma В16 were performed. Dynamics of drug accumulation in tumor and normal tissue (level of accumulation in tissues was assessed by means of fl uorescence) was studied. For intraperitoneal injection at a dose of 5 mg/kg the drug was shown to accumulate gradually in tumor and normal tissues with maximal fl uorescence values in 2–3 h after injection. Then fl uorescence intensity in tissues gradually decreased, achieving nearly initial base-line in 120 h after beginning of the study. The hotosensitizer accumulated in tumor tissue with average selectivity: contrast index for maximal drug accumulation in tissues accounted for 1.7–2.8. According to obtained data for following research the time interval between drug injection and irradiation of 3h was chosen. On the second stage of the study dependence of photodynamic therapy effi cacy on different parameters including photosensitizer dose for intraperitoneal injection (5–10 mg/kg), light dose (150–300 J/cm2) and power density (0.25–0.51 mW/cm2). The irradiation was performed by semiconductor laser on wavelength of 662±1 nm. The effi cacy was maximal for following regimen: photosensitizer dose of 5 mg/kg, light dose of 300 J/cm2, power intensity of 0.44 mW/cm2. For this regimen at the end of follow-up (21 days) complete tumor regression was obtained in 75% of animals and average coeffi cient of absolute tumor growth accounted for only 7.82.https://www.pdt-journal.com/jour/article/view/55photodynamic therapyfotogemphotosensalasensfotoditazinradachlorine
spellingShingle Yu. S. Osipchuk
M. A. Kaplan
V. V. Drozhzhina
Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
Biomedical Photonics
photodynamic therapy
fotogem
photosens
alasens
fotoditazin
radachlorine
title Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
title_full Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
title_fullStr Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
title_full_unstemmed Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
title_short Photodynamic therapy of melanoma B16 in mice with the new photosensitizer boronated chlorine
title_sort photodynamic therapy of melanoma b16 in mice with the new photosensitizer boronated chlorine
topic photodynamic therapy
fotogem
photosens
alasens
fotoditazin
radachlorine
url https://www.pdt-journal.com/jour/article/view/55
work_keys_str_mv AT yusosipchuk photodynamictherapyofmelanomab16inmicewiththenewphotosensitizerboronatedchlorine
AT makaplan photodynamictherapyofmelanomab16inmicewiththenewphotosensitizerboronatedchlorine
AT vvdrozhzhina photodynamictherapyofmelanomab16inmicewiththenewphotosensitizerboronatedchlorine